← Leaderboards
Shigeki Saito
Tulane University Of Louisiana
$769,500
Attributed
$769,500
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $229.5K · FY2020–25$250K$187.5K$125K$62.5K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$769,500 · 2
By mechanism
K08$540,000 · 1
R03$229,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Luis A. Ortiz$9,714,867
- Joseph A Lasky$7,533,299
- Jay K Kolls$45,526,904
- Yusuke Higashi$215,369
Others in their field
Other Emerging Leaders on “Resolution”
- Laura Ferrarese · Association Of Universities For Research In Astronomy, Inc.$47,742,424
- Gary Kobinger · University Of Texas Med Br Galveston$34,500,000
- Evan Z Macosko · Broad Institute, Inc.$32,146,449
- Jean Macdonald · Dana-Farber Cancer Inst$26,990,229
- Priyamvada Acharya · Duke University$16,413,129
- Hemali Phatnani · New York University School Of Medicine$16,349,331
Research focus
ResolutionCellsMediatingRegulationFibrosisTranscriptomeIdiopathic Pulmonary FibrosisLung DiseasesPirfenidonePulmonary FibrosisFibroblastsCell TypeBiologicalSingle-Cell Rna SequencingGenesGenetically Engineered MouseBleomycinLungMouse ModelPharmaceutical PreparationsEffective TherapyProteinsChromatin ImmunoprecipitationChromatin
Grant awards (5)
RECK in Pulmonary Fibrosis$229,500
R03 · FY2025 · HL · contact PI
Inhibition of Histone Deacetylase 8 (HDAC8) as a Therapy for Pulmonary Fibrosis$135,000
K08 · FY2023 · HL · contact PI
Inhibition of Histone Deacetylase 8 (HDAC8) as a Therapy for Pulmonary Fibrosis$135,000
K08 · FY2022 · HL · contact PI
Inhibition of Histone Deacetylase 8 (HDAC8) as a Therapy for Pulmonary Fibrosis$135,000
K08 · FY2021 · HL · contact PI
Inhibition of Histone Deacetylase 8 (HDAC8) as a Therapy for Pulmonary Fibrosis$135,000
K08 · FY2020 · HL · contact PI